XORTX Therapeutics Inc. filed a 6-K document on March 25, 2025, indicating compliance with SEC regulations and included financial statements for the years ending December 31, 2024, 2023, and 2022.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.